N-AMIDE DERIVATIVES OF 8-AZABICYCLO[3.2.1]OCT-3-YL AS CCR1 ANTAGONISTS
摘要
<p>The present invention relates to new antagonists of the interaction between the CCR1 Chemokine receptor and its ligands, including MIP-1a (CCL3), in particular new N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl of formula (I).</p>
